WHO ICTRP trial
Study on the safety of remidazolam toluenesulfonate combined with sufentanil in…
ChiCTR2300069412 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300069412 |
|---|---|
| Public title | Study on the safety of remidazolam toluenesulfonate combined with sufentanil in painless ultrasonic gastroscopy |
| Scientific title | Study on the safety of remidazolam toluenesulfonate combined with sufentanil in painless ultrasonic gastroscopy |
| Primary sponsor | The Affiliated Hospital of Guizhou Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Interventions | Rima Group:Remazolam toluenesulfonate administered;Propofol group:Administration of propofol |
| Registration date | Mar 15, 2023 |
| Target size | Rima Group:40;Propofol group:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: